Publications

Eposter / Safety Evaluation of Christensenella minuta as a Novel Microbiome-based Biotherapy to Treat Obesity

Nov 1, 2021

We are pleased to present our poster highlighting safety and first efficacy results of our Xla1 biotherapy targeting obesity and its associated metabolic disorders.

Access this poster

 

 

In the same category

Publications

Selection of a novel strain of Christensenella minuta as a future biotherapy for Crohn’s disease

Apr 11, 2022

more +
Publications

Species-targeted sorting and cultivation of commensal bacteria from the gut microbiome using flow...

Feb 16, 2022

more +
Publications

Next Generation Microbiome Research: Identification of Keystone Species in the Metabolic Regulation...

Sep 1, 2021

more +

YSOPIA Bioscience © 2022 - all rights reserved terms and conditions